Third Rock-backed au­toim­mune biotech turns off the lights

A Third Rock Ven­tures biotech cre­at­ed to make new med­i­cines for au­toim­mune and in­flam­ma­to­ry dis­eases has shut­tered, End­points News has learned.

Rheos Med­i­cines changed its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER